Page last updated: 2024-08-21

hydrazine and Neuroendocrine Tumors

hydrazine has been researched along with Neuroendocrine Tumors in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Camargo, EE; Cantoni, S; Corradi, G; Costa, FP; de Almeida Filho, JG; de Oliveira Santos, A; Etchebehere, EC; Gumz, B; Hoff, PG; Ichiki, WA; Vicente, A1
Cera, PJ; Cha, SS; Creagan, ET; Goldberg, RM; Jung, SH; Marschke, RF; Myers, JL; Schleusener, JT; Tazelaar, HD1

Trials

1 trial(s) available for hydrazine and Neuroendocrine Tumors

ArticleYear
Neuroendocrine differentiation is an independent prognostic factor in chemotherapy-treated nonsmall cell lung carcinoma.
    Cancer, 1996, Apr-01, Volume: 77, Issue:7

    Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cell Differentiation; Cisplatin; Disease Progression; Etoposide; Female; Humans; Hydrazines; Immunohistochemistry; Lung Neoplasms; Male; Middle Aged; Multivariate Analysis; Neuroendocrine Tumors; Prognosis; Staining and Labeling

1996

Other Studies

1 other study(ies) available for hydrazine and Neuroendocrine Tumors

ArticleYear
68Ga-DOTATATE PET/CT, 99mTc-HYNIC-octreotide SPECT/CT, and whole-body MR imaging in detection of neuroendocrine tumors: a prospective trial.
    Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2014, Volume: 55, Issue:10

    Topics: Adult; Aged; Algorithms; Biopsy; Female; Humans; Hydrazines; Magnetic Resonance Imaging; Male; Middle Aged; Neuroendocrine Tumors; Nicotinic Acids; Octreotide; Organometallic Compounds; Positron-Emission Tomography; Prospective Studies; Technetium; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed; Whole Body Imaging

2014